cripto-1 mAbs (Bioceros)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug Namecripto-1 mAbs (Bioceros)
Drug Alias Nameanticancer antibodies (Oncomab/Medarex)cripto-1 mAb (Prima BioMed)cripto-1 mAbs (Bioceros/Oncomab)anti-cripto-1 antibodies (Austin Research Institute/Prima BioMed/Medarex)Oncomab +[6] 
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionImmunomodulatorsT lymphocytes modulators
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlandsAustralia and New Zealand
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAustin Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAustin Research InstituteBiocerosOncomab Gmbh +[4] 
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A